Kaiser Permanente Washington Health Research Institute

Category

Kaiser Permanente Washington Health Research Institute Doses First Patient for COVID-19 Vaccine with Moderna’s mRNA-1273

A Phase I clinical trial evaluating Moderna’s mRNA-1273 to fight against COVID-19 commenced at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle—the clinical investigational site was able to dose the first patient. The National Institute of...

Pin It on Pinterest